Lea Bio Inc. is pleased to announce that it has signed a Memorandum of Understanding (MOU) with a medical institution operated by Hoan My Group, Vietnam’s largest private medical network with 14 hospitals and 7 clinics across Vietnam, for the purpose of developing new services or continuing to use MEQUY, which is currently provided by Lea Bio.
In recent years, Vietnam’s medical needs have been rapidly increasing in line with its economic growth. However, a shortage of medical personnel such as doctors and nurses, and excessive workloads at medical treatment sites are serious issues. Particularly in emergency outpatient clinics and primary care settings, there is a need to accurately grasp patients’ conditions and make quick triage decisions within a limited time frame.
In response to this situation, Lea Bio’s new “MEQUY AI Triage” provides a system in which AI supports initial assessments based on information obtained from patients, such as symptoms and medical history, with the aim of reducing the burden on medical professionals and contributing to improving the quality of medical care.
こちらもお読みください: ConcertAI、がんAIツールにASCO®自動化を追加
一方、ホアンミーグループが運営する医療機関は、全国に多数の病院・クリニックを展開するベトナム最大の民間医療グループ。質の高い医療の提供に加え、デジタルヘルス導入にも積極的に取り組む最先端の医療機関として知られています。
The two companies have agreed to a strategic partnership to explore practical solutions that utilize AI technology to address issues in Vietnam’s medical field, leading to the conclusion of this MOU.
The purpose of this partnership is to further evolve the “MEQUY” service that Lea Bio has been providing to medical institutions in Vietnam and to realize improved efficiency and quality of medical care through practical application in clinical settings in Vietnam.
Lea Bio was established in Japan in 2019 and established a Vietnamese subsidiary in 2022. With the mission of “delivering equal medical care to children around the world through information power,” the company promotes the development of technologies related to prevention, nutrition, and medical support, and has been working on digitalizing medical care in many areas, including elderly care, prevention of lifestyle-related diseases, and the construction of nutrition management systems in Vietnam.
今回の提携により、リーア・バイオはホアン・マイ・グループと共同で、救急外来や内科外来での現場導入に向けた概念実証(PoC)を実施し、患者から得た症状や病歴などの情報をもとにAIが病気の緊急度や可能性を予測し、医療従事者がより迅速で正確な判断を下せるよう支援します。
ホアンミーグループにとって、医療プロセスを合理化・標準化するためのAIの導入は、質の高い医療サービスを持続的に提供するために非常に重要であり、今回の提携は両社のデジタルヘルス戦略における重要なマイルストーンとなります。
今後について リー・バイオ and Hoan My Group will jointly create innovative solutions using AI technology to address the challenges facing Vietnam’s medical field, and will promote progressive efforts with a view to future nationwide expansion and collaboration with medical policies.
ソース PRタイムズ
